Role of radiotherapy and chemotherapy in the risk of secondary leukaemia after a solid tumour in childhood
Authors:
- Nadia HaddyNHNadia Haddy
- Marie Cécile Le DeleyMDMarie Cécile Le Deley
- Florent de VathaireFVFlorent de Vathaire
- 1 November 2006
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 42 (16) , 2757-2764
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The risk of developing second cancers among survivors of childhood soft tissue sarcomaCancer, 2005
- Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatmentBritish Journal of Cancer, 1999
- Phase II study of 21 day schedule oral etoposide in childrenEuropean Journal of Cancer, 1997
- Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhoodThe Lancet, 1997
- Radiotherapy, Alkylating Agents, and Risk of Bone Cancer After Childhood CancerJNCI: Journal of the National Cancer Institute, 1996
- Risk of Leukemia Following Treatment for Non-Hodgkin's LymphomaJNCI: Journal of the National Cancer Institute, 1994
- Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer.BMJ, 1992
- Chronic oral etoposideCancer, 1991
- Role of radiotherapy and chemotherapy in the risk of second malignant neoplasms after cancer in childhoodBritish Journal of Cancer, 1989
- Bone Sarcomas Linked to Radiotherapy and Chemotherapy in ChildrenNew England Journal of Medicine, 1987